Greenlane Holdings, Inc. — Form 8-K Summary
Business Context and Reporting Period
Greenlane Holdings, Inc. filed a Form 8-K under Item 4.02 on November 10, 2023, reporting that previously issued financial statements for certain periods should no longer be relied upon. The affected periods are the quarters ended September 30, 2022, March 31, 2023, and June 30, 2023, and the year ended December 31, 2022.
Financial Impact
- The Company determined that it applied the impairment testing guidance in ASC 360-10-35 and ASC 350-10 in the wrong sequence.
- As a result, definite-lived intangible assets were overstated in the affected financial statements.
- The Company estimates an approximately $50.7 million non-cash impairment charge related to the correction in the third quarter of 2022.
- Related amortization expense in subsequent periods is expected to be reversed.
- The corrections do not affect reported operating revenues or cost of goods sold.
- The filing does not provide a clear quantified impact on net income, assets, equity, cash flow, margins, debt, or liquidity because the review remains ongoing.
Material Changes and Restatement
The Company concluded that the accounting error has a material impact on its previously filed financial statements. The affected statements will be restated through amended Forms 10-K/A and 10-Q/A, as applicable.
The Company had not completed its review as of the filing date and was unable to quantify the full effect of the corrections across all affected periods.
Outlook, Risks, and Unusual Items
- The Company expects to file the restated financial statements as soon as reasonably practical, but the filing does not provide a specific filing date.
- The estimated impairment and related adjustments are non-cash items, although they may materially affect reported earnings, asset balances, amortization, and equity for the affected periods.
- Forward-looking statements regarding the timing of the restatements are subject to execution, accounting review, and other risks described in the Company’s SEC filings.
- The Audit Committee, management, and Marcum LLP discussed the matters disclosed in the filing.
Key Facts for Investors to Verify
- Review the amended Forms 10-K/A and 10-Q/A when filed for the final impairment charge and period-by-period effects.
- Verify the revised intangible asset balances, amortization expense, net loss, retained earnings, and stockholders’ equity.
- Confirm whether the restatement affects any debt covenants, liquidity measures, or other contractual requirements.
- Assess whether the accounting correction indicates broader weaknesses in impairment testing or internal controls.
- Confirm that operating revenues, cost of goods sold, and cash flow remain unchanged as stated in the 8-K.